Cathie Wood's position in Adaptive Biotechnologies is currently worth $27.6 Million. That's 0.22% of their equity portfolio (63rd largest holding). The investor owns 8.14% of the outstanding Adaptive Biotechnologies stock. The first Adaptive Biotechnologies trade was made in Q2 2020. Since then Cathie Wood bought shares thirteen more times and sold shares on two occasions. The investor's estimated purchase price is $262 Million, resulting in a loss of 89%.